Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Delivers 475% More CBD to the Bloodstream
LXRP’s DehydraTECH has been shown to outperform conventional cannabis formulations and deliver 475 percent more CBD to the bloodstream in the first 15 minutes Compared to other industry formulations, DehydraTECH delivered cannabinoids quicker at industry-leading volumes A DehydraTECH formulation achieved a 319 percent higher CBD blood concentration level at 60 minutes than the generic coconut oil formulation Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH delivery technology has demonstrated in animal lab tests that it can deliver cannabinoids to the bloodstream more quickly than conventional cannabinoid formulations (http://cnw.fm/YT1r4). At 15 minutes into the test, the DehydraTECH formulation achieved a…